par Phillips, Kelly-Anne;Aldridge, Julie;Ribi, Karin;Sun, Zhuoxin;Thompson, Alastair;Harvey, Vernon;Thürlimann, Beat;Cardoso, Fatima ;Pagani, Olivia;Coates, Alan;Goldhirsch, Aron;Price, Karen N.;Gelber, Richard;Bernhard, Jürg
Référence Breast cancer research and treatment, 126, 1, page (221-226)
Publication Publié, 2011-02
Référence Breast cancer research and treatment, 126, 1, page (221-226)
Publication Publié, 2011-02
Article révisé par les pairs
Titre: |
|
Auteur: | Phillips, Kelly-Anne; Aldridge, Julie; Ribi, Karin; Sun, Zhuoxin; Thompson, Alastair; Harvey, Vernon; Thürlimann, Beat; Cardoso, Fatima; Pagani, Olivia; Coates, Alan; Goldhirsch, Aron; Price, Karen N.; Gelber, Richard; Bernhard, Jürg |
Informations sur la publication: | Breast cancer research and treatment, 126, 1, page (221-226) |
Statut de publication: | Publié, 2011-02 |
Sujet CREF: | Cancérologie |
Mots-clés: | Aromatase inhibitor |
Breast cancer | |
Cognitive function | |
Letrozole | |
Quality of life | |
Tamoxifen | |
Note générale: | SCOPUS: ar.j |
Langue: | Anglais |
Identificateurs: | urn:issn:0167-6806 |
info:doi/10.1007/s10549-010-1235-y | |
info:scp/79151479469 | |
info:pmid/21046229 |